EMWA’s Special Interest Group on Medical Communication initiated a reply to an article that made unfounded derogatory remarks about medical writers (MWs). Without providing any evidence, in an article about the development of randomised clinical trials in oncology (doi:10.1001/jamaoncol.2021.0379), the authors Del Paggio JC, Berry JS; Hopman WM et al. state: